Assessment of the RTS,S/AS01 malaria vaccine.

Moorthy, V S; Newman, R D; Duclos, P; Okwo-Bele, J M; Smith, P G

Moorthy, V S; Newman, R D; Duclos, P; Okwo-Bele, J M; Smith, P G.

Affiliation

Moorthy VS; Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland. moorthyv@who.int

Lancet Infect Dis ; 13(4): 280-2, 2013 Apr.

Article in En | MEDLINE | ID: mdl-23454165

Subject(s)

Adjuvants, Immunologic/administration & dosage; Malaria Vaccines/immunology; Malaria, Falciparum/epidemiology; Malaria, Falciparum/prevention & control; Malaria, Falciparum/transmission; Plasmodium falciparum/immunology; Female; Humans; Male

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Plasmodium falciparum / Adjuvants, Immunologic / Malaria, Falciparum / Malaria Vaccines Limits: Female / Humans / Male Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2013 Document type: Article Affiliation country: Switzerland Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google